| Year |
Citation |
Score |
| 2005 |
Holm TM, Jackson-Grusby L, Brambrink T, Yamada Y, Rideout WM, Jaenisch R. Global loss of imprinting leads to widespread tumorigenesis in adult mice. Cancer Cell. 8: 275-85. PMID 16226703 DOI: 10.1016/J.Ccr.2005.09.007 |
0.45 |
|
| 2004 |
Hochedlinger K, Rideout WM, Kyba M, Daley GQ, Blelloch R, Jaenisch R. Nuclear transplantation, embryonic stem cells and the potential for cell therapy. The Hematology Journal : the Official Journal of the European Haematology Association / Eha. 5: S114-7. PMID 15190291 DOI: 10.1038/Sj.Thj.6200435 |
0.396 |
|
| 2004 |
Gaudet F, Rideout WM, Meissner A, Dausman J, Leonhardt H, Jaenisch R. Dnmt1 expression in pre- and postimplantation embryogenesis and the maintenance of IAP silencing. Molecular and Cellular Biology. 24: 1640-8. PMID 14749379 DOI: 10.1128/Mcb.24.4.1640-1648.2004 |
0.342 |
|
| 2002 |
Jaenisch R, Eggan K, Humpherys D, Rideout W, Hochedlinger K. Nuclear cloning, stem cells, and genomic reprogramming. Cloning and Stem Cells. 4: 389-396. PMID 12630413 DOI: 10.1089/153623002321025069 |
0.324 |
|
| 2002 |
Rideout WM, Hochedlinger K, Kyba M, Daley GQ, Jaenisch R. Correction of a genetic defect by nuclear transplantation and combined cell and gene therapy. Cell. 109: 17-27. PMID 11955443 DOI: 10.1016/S0092-8674(02)00681-5 |
0.405 |
|
| 2001 |
Rideout WM, Eggan K, Jaenisch R. Nuclear cloning and epigenetic reprogramming of the genome. Science (New York, N.Y.). 293: 1093-8. PMID 11498580 DOI: 10.1126/Science.1063206 |
0.393 |
|
| 2001 |
Humpherys D, Eggan K, Akutsu H, Hochedlinger K, Rideout WM, Biniszkiewicz D, Yanagimachi R, Jaenisch R. Epigenetic instability in ES cells and cloned mice. Science (New York, N.Y.). 293: 95-7. PMID 11441181 DOI: 10.1126/Science.1061402 |
0.426 |
|
| 2001 |
Eggan K, Akutsu H, Loring J, Jackson-Grusby L, Klemm M, Rideout WM, Yanagimachi R, Jaenisch R. Hybrid vigor, fetal overgrowth, and viability of mice derived by nuclear cloning and tetraploid embryo complementation. Proceedings of the National Academy of Sciences of the United States of America. 98: 6209-14. PMID 11331774 DOI: 10.1073/Pnas.101118898 |
0.326 |
|
| 2000 |
Rideout WM, Wakayama T, Wutz A, Eggan K, Jackson-Grusby L, Dausman J, Yanagimachi R, Jaenisch R. Generation of mice from wild-type and targeted ES cells by nuclear cloning. Nature Genetics. 24: 109-10. PMID 10655052 DOI: 10.1038/72753 |
0.317 |
|
| 1999 |
Kato Y, Rideout WM, Hilton K, Barton SC, Tsunoda Y, Surani MA. Developmental potential of mouse primordial germ cells Development. 126: 1823-1832. PMID 10101117 |
0.382 |
|
| 1997 |
Gonzalgo ML, Liang G, Spruck CH, Zingg JM, Rideout WM, Jones PA. Identification and characterization of differentially methylated regions of genomic DNA by methylation-sensitive arbitrarily primed PCR. Cancer Research. 57: 594-9. PMID 9044832 |
0.344 |
|
| 1994 |
Rideout WM, Eversole-Cire P, Spruck CH, Hustad CM, Coetzee GA, Gonzales FA, Jones PA. Progressive increases in the methylation status and heterochromatinization of the myoD CpG island during oncogenic transformation Molecular and Cellular Biology. 14: 6143-6152. PMID 8065347 DOI: 10.1128/Mcb.14.9.6143 |
0.424 |
|
| 1994 |
Schmutte C, Rideout WM, Shen JC, Jones PA. Mutagenicity of nitric oxide is not caused by deamination of cytosine or 5-methylcytosine in double-stranded DNA Carcinogenesis. 15: 2899-2903. PMID 8001253 DOI: 10.1093/Carcin/15.12.2899 |
0.345 |
|
| 1992 |
Jones PA, Rideout WM, Shen J‐, Spruck CH, Tsai YC. Methylation, mutation and cancer Bioessays. 14: 33-36. PMID 1546979 DOI: 10.1002/Bies.950140107 |
0.411 |
|
| 1992 |
Shen JC, Rideout WM, Jones PA. High frequency mutagenesis by a DNA methyltransferase Cell. 71: 1073-1080. PMID 1473145 DOI: 10.1016/S0092-8674(05)80057-1 |
0.364 |
|
| 1991 |
Rideout WM, Coetzee GA, Olumi AF, Spruck CH, Jones PA. 5-Methylcytosine as an endogenous mutagen in the p53 tumor suppressor gene Princess Takamatsu Symposia. 22: 207-219. PMID 1844242 |
0.37 |
|
| 1990 |
Jones PA, Wolkowicz MJ, Rideout WM, Gonzales FA, Marziasz CM, Coetzee GA, Tapscott SJ. De novo methylation of the MyoD1 CpG island during the establishment of immortal cell lines Proceedings of the National Academy of Sciences of the United States of America. 87: 6117-6121. PMID 2385586 DOI: 10.1073/Pnas.87.16.6117 |
0.428 |
|
| 1990 |
Rideout WM, Coetzee GA, Olumi AF, Jones PA. 5-Methylcytosine as an endogenous mutagen in the human LDL receptor and p53 genes Science. 249: 1288-1290. PMID 1697983 DOI: 10.1126/Science.1697983 |
0.406 |
|
| Show low-probability matches. |